DK3209307T3 - Probiotiske og præbiotiske sammensætninger - Google Patents
Probiotiske og præbiotiske sammensætninger Download PDFInfo
- Publication number
- DK3209307T3 DK3209307T3 DK15784636.1T DK15784636T DK3209307T3 DK 3209307 T3 DK3209307 T3 DK 3209307T3 DK 15784636 T DK15784636 T DK 15784636T DK 3209307 T3 DK3209307 T3 DK 3209307T3
- Authority
- DK
- Denmark
- Prior art keywords
- probiotic
- prebiotic compositions
- prebiotic
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14382412 | 2014-10-21 | ||
| PCT/EP2015/074375 WO2016062771A1 (en) | 2014-10-21 | 2015-10-21 | Probiotic and prebiotic compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3209307T3 true DK3209307T3 (da) | 2023-01-09 |
Family
ID=51846603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15784636.1T DK3209307T3 (da) | 2014-10-21 | 2015-10-21 | Probiotiske og præbiotiske sammensætninger |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10179153B2 (da) |
| EP (1) | EP3209307B1 (da) |
| JP (1) | JP6765370B2 (da) |
| KR (1) | KR102517581B1 (da) |
| CN (1) | CN107073049B (da) |
| AU (1) | AU2015334989B2 (da) |
| BR (1) | BR112017008184B1 (da) |
| CA (1) | CA2965214C (da) |
| DK (1) | DK3209307T3 (da) |
| ES (1) | ES2936842T3 (da) |
| PH (1) | PH12017500708A1 (da) |
| PL (1) | PL3209307T3 (da) |
| RU (1) | RU2741836C2 (da) |
| WO (1) | WO2016062771A1 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10624934B2 (en) | 2014-03-06 | 2020-04-21 | Research Institute At Nationwide Children's Hospital | Prebiotic formulations |
| EP3113630B1 (en) * | 2014-03-06 | 2019-12-11 | The Research Institute at Nationwide Children's Hospital | Probiotic formulations and methods for use |
| US11959125B2 (en) | 2016-09-15 | 2024-04-16 | Sun Genomics, Inc. | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
| KR101851297B1 (ko) * | 2017-02-13 | 2018-04-23 | 강원대학교 산학협력단 | 신규한 락토바실러스 루테리 균주 및 그 항균 용도 |
| EP3648769A4 (en) * | 2017-06-30 | 2021-04-07 | The Rockefeller University | N-ACYL AMIDES DERIVED FROM THE HUMAN MICROBIOTE FOR THE TREATMENT OF HUMAN DISEASE |
| KR20190070457A (ko) | 2017-12-13 | 2019-06-21 | 주식회사 오투파워 | 이산화염소를 포함하는 닭 대장균증 예방을 위한 음용수 첨가용 조성물 |
| CN109385387B (zh) * | 2018-12-28 | 2022-04-05 | 上海源耀农牧科技有限公司 | 一种抗tgev的罗伊氏乳杆菌及其应用 |
| CN112877231B (zh) * | 2019-11-29 | 2023-06-23 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 具有抑菌和抗氧化活性的乳酸菌及其应用 |
| WO2021195577A2 (en) * | 2020-03-26 | 2021-09-30 | Persephone Biosciences, Inc. | Compositions for modulating gut microflora populations, enhancing drug potency and treating viral infections, and methods for making and using same |
| US20230340625A1 (en) * | 2020-04-13 | 2023-10-26 | Sun Genomics, Inc. | Method and system for detecting and treating exposure to an infectious pathogen |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1034788A1 (en) | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactic acid bacteria strains capable of preventing diarrhea |
| WO2004076657A2 (en) * | 2003-02-28 | 2004-09-10 | Mcgill University | Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides |
| AU2003247193A1 (en) * | 2003-07-23 | 2005-02-04 | M.D.Lab Corp. | Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus |
| KR100513168B1 (ko) * | 2003-08-27 | 2005-09-07 | 주식회사 프로바이오닉 | 돼지 유행성 설사증 (PED) 코로나바이러스 및 유해 미생물 억제 활성을 가지는 신규 내 산성 엔테로코커스 훼카리스Probio-056 및 이를 함유하는 생균활성제 |
| EP1997499A1 (en) * | 2007-05-31 | 2008-12-03 | Puleva Biotech, S.A. | Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis |
| CA2783414A1 (en) * | 2012-07-22 | 2014-01-22 | Integral Medical Inc. | Probiotic composition |
| RU2665815C2 (ru) * | 2012-09-25 | 2018-09-04 | Акилон Киль, Сл | Композиция пробиотиков и пребиотиков |
-
2015
- 2015-10-21 WO PCT/EP2015/074375 patent/WO2016062771A1/en active Application Filing
- 2015-10-21 RU RU2017113027A patent/RU2741836C2/ru active
- 2015-10-21 EP EP15784636.1A patent/EP3209307B1/en active Active
- 2015-10-21 ES ES15784636T patent/ES2936842T3/es active Active
- 2015-10-21 AU AU2015334989A patent/AU2015334989B2/en active Active
- 2015-10-21 JP JP2017521096A patent/JP6765370B2/ja active Active
- 2015-10-21 CN CN201580057157.0A patent/CN107073049B/zh active Active
- 2015-10-21 CA CA2965214A patent/CA2965214C/en active Active
- 2015-10-21 KR KR1020177013629A patent/KR102517581B1/ko active IP Right Grant
- 2015-10-21 DK DK15784636.1T patent/DK3209307T3/da active
- 2015-10-21 US US15/520,622 patent/US10179153B2/en active Active
- 2015-10-21 PL PL15784636.1T patent/PL3209307T3/pl unknown
- 2015-10-21 BR BR112017008184-9A patent/BR112017008184B1/pt not_active IP Right Cessation
-
2017
- 2017-04-17 PH PH12017500708A patent/PH12017500708A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20170088847A (ko) | 2017-08-02 |
| KR102517581B1 (ko) | 2023-04-03 |
| US10179153B2 (en) | 2019-01-15 |
| RU2741836C2 (ru) | 2021-01-29 |
| BR112017008184B1 (pt) | 2021-10-19 |
| ES2936842T3 (es) | 2023-03-22 |
| CN107073049A (zh) | 2017-08-18 |
| US20170312321A1 (en) | 2017-11-02 |
| RU2017113027A (ru) | 2018-11-22 |
| PL3209307T3 (pl) | 2023-05-22 |
| AU2015334989B2 (en) | 2020-10-08 |
| EP3209307B1 (en) | 2022-10-05 |
| CA2965214C (en) | 2022-01-11 |
| WO2016062771A1 (en) | 2016-04-28 |
| JP6765370B2 (ja) | 2020-10-07 |
| EP3209307A1 (en) | 2017-08-30 |
| CA2965214A1 (en) | 2016-04-28 |
| JP2017533197A (ja) | 2017-11-09 |
| RU2017113027A3 (da) | 2019-05-29 |
| AU2015334989A1 (en) | 2017-04-20 |
| CN107073049B (zh) | 2021-12-14 |
| BR112017008184A2 (pt) | 2017-12-26 |
| PH12017500708A1 (en) | 2017-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2535253B (en) | Compositions and methods | |
| ZA201803451B (en) | Probiotic compositions and uses thereof | |
| DK3234133T3 (da) | Crispr-baserede sammensætninger og fremgangsmåder til anvendelse | |
| ZA201701286B (en) | Flagellin compositions and uses | |
| DK3169741T3 (da) | Forbedrede bindemiddelsammensætninger og anvendelser deraf | |
| DK3495023T3 (da) | Semifluorerede forbindelser og sammensætninger deraf | |
| ZA201702213B (en) | Interleukin-15 compositions and uses thereof | |
| DK3145493T3 (da) | Fremgangsmåder og sammensætninger vedrørende exosomer | |
| DK3015526T3 (da) | Hydrofluorolefinbaseret sammensætning og anvendelse deraf | |
| DK3218358T3 (da) | Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner | |
| GB2535423B (en) | Cementing compositions and methods | |
| IL250568A0 (en) | Anti-methanogenic preparations and their uses | |
| KR20180084891A (ko) | 구조 조성물 및 방법 | |
| DK3209307T3 (da) | Probiotiske og præbiotiske sammensætninger | |
| HUE044571T2 (hu) | Módosított ciklopentapeptidek és alkalmazásaik | |
| DK3194564T3 (da) | Trichodermasammensætninger og anvendelsesfremgangsmåder | |
| GB201417828D0 (en) | New methods and compositions | |
| DK3220750T3 (da) | Oral rehydreringssammensætning og fremgangsmåder dertil | |
| DK3212776T3 (da) | Sammensætninger og fremgangsmåder i forbindelse med beta-glucosidase | |
| DK3209773T3 (da) | Prolintolerante tripeptidylpeptidaser og anvendelser deraf | |
| DK3161139T3 (da) | Tlr-4-specifikke aptamerer og anvendelser heraf | |
| DK3223796T3 (da) | Farmaceutiske sammensætninger, fremstilling og anvendelser deraf | |
| DK3191757T3 (da) | Kobling og tætning | |
| DK3365321T3 (da) | Solabegron-zwitterion og anvendelser deraf | |
| DK3337506T3 (da) | Kombinationer og anvendelser deraf |